Furthermore, they mediate tumor angiogenesis [25,29] and CXCR2 has been shown to be a driving force on the vascular mimicry (VM) formation in GBM patients, indicating a key role of this signaling pathway in the tumor blood supply [25,30]. The gene discussed is CXCR2; the disease is glioblastoma.